Co-Organizer








Guangzhou KingMed Diagnostics Group Co., Ltd.(KingMed Diagnostics, SSE 603882), is based in Guangzhou International Biological Island. Since 1990, Kingmed was actively exploring the medical inspection outsourcing services in China's business model.Relying on a deep understanding and rich experiences in the industry, Kingmed Diagnostics was established in 2003. Kingmed was regarded as the forerunner ofIndependent Clinical Laboratories (ICL)in China.


As a benchmark for the third-party medical industry, Kingmed has always put clinical needs in the first place. With disease-oriented, Kingmed set up the detection and diagnosis center. This centeradopts international advanced medical testing technology and service concept to build a core technology system in China, with the help of high-end talent at home and abroad and independent innovation. Strictly follow the international standard, Kingmed is the first ICL with CAP and ISO15189 certificate. Inspection report issued by Kingmedis approved in more than 50 countries and regions. Through the international standard and innovation, Kingmed continuously improves the inspection and testing capabilities to mainly provide medical testing services. It provides more than 2,400 kind of test for clinical and scientific research, which is one of the medical institutions offering more complete of inspection items in China. At present, Kingmed in mainland China and Hong Kong has set up 35 medical laboratories. It has the on-site service network in township and community level by establishing the headquarters of the laboratory, provincial-region center laboratory, provincial laboratory, and the city-level laboratory. Kingmedprovides medical testing services for more than 21,000 medical institutions. Its annual testing samples exceed 40 million specimens, covering the area with more than 90% of the population in China. Kingmed group has the first remote pathological network in China and pathology doctor group with more than 600 domestic and foreign pathologists. It solves the dilemma of current scarcity of pathology by the market-oriented mode,assists grading diagnosis and treatment, and promotes equalization of medical public services.


In Thirteen-Five period, Kingmedputs forward " Diagnostics +" development strategy in order to practice the innovation-driven development strategy based on the innovation of science and technology,relying on the nationwide service outlets, quality test and inspection capability, and the big inspection data. Kingmed builds inspection platform to realize the following trans-boundary integration of the ecological circle:

· Research the downstream industrial chain of medical inspectionin-depth and build the platform of vitro diagnostic products (IVD);
· Aim at medical treatment and dig into the inspection data to build a large data platform of health care, and actively explore the new mode of internet and mobile medicine;
· Provide more large-health integrated testing services program in the judicial identification, clinical trials, health examination, food hygiene testing, cold chain logistics, etc.